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Abstract
The pre-erythrocytic stages of Plasmodium spp. are increasingly recognised as ideal targets for prophylactic
vaccines and drug treatments. Intense research efforts in the last decade have been focused on in vitro culture and
in vivo detection and quantification of liver stage parasites to assess the effects of candidate vaccines or drugs.
Typically, the onset of blood stage parasitaemia is used as a surrogate endpoint to estimate the efficacy of vaccines
and drugs targeting pre-erythrocytic parasite stages in animal models. However, this provides no information on the
parasite burden in the liver after vaccination or treatment and therefore does not detect partial efficacy of any vaccine
or drug candidates. Herein, we describe a quantitative RT-PCR method adapted to detect and quantitate
Plasmodium yoelii liver stages in mice with increased sensitivity even after challenge with as few as 50
cryopreserved sporozoites (corresponding to approximately 5-10 freshly isolated sporozoites). We have validated our
quantitative RT-PCR assay according to the MIQE (Minimum Information for Publication of Quantitative Real-Time
PCR Experiments) guidelines and established high reproducibility and accuracy. Our assay provides a rapid and
reproducible assessment of liver stage parasite burden in rodent malaria models, thereby facilitating the evaluation of
the efficacy of anti-malarial drugs or prophylactic vaccines with high precision and efficacy.
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Introduction
Malaria is a vector-borne disease, caused by the
apicomplexan parasite Plasmodium spp. and transmitted by
Anopheles mosquitoes. Upon taking a blood meal, an infected
female mosquito injects Plasmodium spp. sporozoites into the
dermis, which then migrate to the liver and go through a pre-
erythrocytic developmental stage within hepatocytes before
initiating the symptomatic erythrocytic stage of the infection
[1,2]. The pre-erythrocytic stage represents a bottleneck in the
parasite development, is clinically silent and therefore regarded
as an ideal point of intervention for prophylactic treatment and
vaccination strategies [3]. Inhibition of parasite growth in
hepatocytes can result in reduction or complete ablation of
erythrocytic stages, thus attenuating or eliminating the
symptoms and the pathology of the disease as well as
preventing further disease transmission. Indeed, infection with
attenuated sporozoites, whose development is halted in the
liver, induces sterile protective immunity [4,5].
The low percentage of host hepatocytes that are infected
after inoculation with Plasmodium spp. sporozoites and the
limited number of available tools pose major obstacles for the
evaluation of liver-stage development and the quantitative
analysis of pre-erythrocytic anti-parasite effects induced by
experimental drug treatments or vaccines in vivo [3]. The
conventional approach to evaluate the effect of an intervention
on liver-stage development in vivo, involves assessment of the
development of blood-stage parasitaemia, via the presence or
absence of parasites in the blood after sporozoite infection
and/or the prepatent period to onset of parasitaemia. The
complete absence of blood-stage parasitaemia indicates sterile
protection. However, such assessment fails to evaluate any
effects directed only at the liver stage or discriminate between
the liver and blood stage for interventions potentially directed at
either or both parasite stages. More direct methods used to
study development of the parasite in the liver in vivo include
histopathologic examination of liver sections [6,7], flow
cytometry of fluorescent protein-tagged parasites [8], intra-vital
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imaging of GFP or luciferase expressing transgene parasites
[1,3], quantitative PCR of ribosomal DNA [9] and real-time
quantitative reverse-transcription PCR (qRT-PCR) [10,11].
qRT-PCR eliminates the requirement for transgenic parasites
used for fluorescence or bioluminescence methods and has
demonstrated high sensitivity for the detection of other
pathogens, where standard (usually microscopic) methods for
quantification are problematic or not sensitive enough to detect
low parasite burdens [12]. We and others have previously
described qRT-PCR methods which can detect liver stage
parasite burden following challenge with relatively high doses
of sporozoites or bites of infected mosquitoes. However, more
sensitive qRT-PCR methods are required to measure parasite
load after challenge with low parasite numbers that are
comparable to those of natural infection [13]. To address this,
we adapted the qRT-PCR method described previously by
Witney et al. [11] to develop a highly sensitive quantitative RT-
PCR assay, which we validated according to the MIQE
(Minimum Information for Publication of Quantitative Real-Time
PCR Experiments) guidelines [14].
Materials and Methods
1. Mice and parasites
Specific pathogen-free BALB/c mice (Animal Resource
Centre, Perth, Australia) were used at 6-10 weeks of age. The
parasite strain used in all experiments was Plasmodium yoelii
17X NL derived from cryopreserved sporozoites provided by
Dr. Stephen Hoffman (Sanaria Inc., Rockville, MD, USA). Mice
were infected with 50-5000 cryopreserved infectious
sporozoites or 1000 heat-inactivated sporozoites in 200µl 1x
PBS/ 2% naive mouse serum injected intravenous (i.v.) into the
tail vein. Cryopreserved sporozoites were inactivated by
incubation at 72°C for 15min and then at 95°C for 15min. For
fluorescent microscopy of live or heat-inactivated sporozoites,
parasites were suspended in µ-slide 18-well slides (Ibidi,
Munich, Germany) with 0.1% SYTOX Blue (Molecular Probes,
Mulgrave, Australia) in 1xPBS; Invitrogen, Life Technologies
Australia Pty Ltd., Mulgrave, VIC). Images were captured using
the DeltaVision Core Microscope System, with Coolsnap HQ
camera and 100x/1.40 oil objective (Applied Precision,
Issaquah, USA). Live sporozoites were motile and excluded
SYTOX Blue; heat-inactivated sporozoites were all non-motile,
crescent-shaped and their nuclei stained with SYTOX Blue.
Mice were euthanized at 40-42h post sporozoite challenge. All
studies were approved by The QIMR Animal Ethics Committee
and were conducted in accordance with the Australian Code of
Practice for the Care and Use of Animals for Scientific
Purposes (2004).
2. RNA extraction
Whole livers were harvested 40-42h after sporozoite
challenge and homogenised in 5ml RNeasy lysis buffer (RLT,
Qiagen Pty Ltd., Chadstone Centre, VIC) with 1% β-2-
mercaptoethanol (Sigma-Aldrich Co. LLC., St. Louis, USA).
RNA was extracted from a 200µl aliquot of the whole liver
homogenate (one twenty-fifth of the whole liver) using the
Qiagen RNeasy Mini kit (Qiagen Pty Ltd.) according to
manufacturer’s instructions. All equipment used during RNA
extraction was cleaned with RNase away wipes (Thermo
Scientific, VWR, Arlington Heights, USA) and exposed to UV-
light for at least 2h prior to use. The A260/A280 ratio of purified
RNA was typically between 1.8 and 2.4 (generally accepted
ratios of A260/A280 for good quality RNA are >1.8) and the
yield between 80µg and 120µg (as measured on PowerWave
HT Microplate Spectrophotometer, BioTek, VT, USA). RNA
samples and aliquots of the liver homogenates were stored at
-80°C. RNA integrity was assessed by gel electrophoresis to
determine the intensity of the large and the small subunit of
ribosomal RNA using Quantity One 1-D Analysis Software (Bio-
Rad Laboratories Pty. Ltd., NSW) (Figure 1A).
3. cDNA synthesis
cDNA was synthesised from 2.5µg RNA using SuperScript®
VILOTM cDNA synthesis kit (Life Technologies) according to
manufacturer’s guidelines. Briefly, cDNA synthesis reactions
were assembled in 20µl on ice and then incubated for 10 mins
at room temperature, followed by 2h at 42°C. The reaction was
terminated by heating the sample to 85°C for 5 mins. cDNA
samples were stored at -20°C.
4. Construction of control plasmids and standard
curves
Two different target sequences were evaluated: 18S rRNA,
the small subunit of ribosomal RNA which is widely used in
qRT-PCR assays [15,16], and cytochrome b (CytB)
mitochondrial DNA (mtDNA), which has been suggested to
provide increased sensitivity through higher abundance [17]. P.
yoelii 17XNL genomic DNA was generated from parasitised red
blood cells (pRBC) of BALB/c mice after infection with
cryopreserved P. yoelii 17XNL sporozoites. Py18S rRNA and
PyCytB mtDNA were amplified by PCR from the P. yoelii
genomic DNA and the amplified full length gene inserts (Figure
1B) were cloned into pGEM-T cloning vector (Invitrogen, Life
Technologies Australia Pty Ltd.) using the TA-cloning method.
These control plasmids were used as external standards. The
Py18S standard curve was generated from a 10-fold dilution
series from 107 to 102 plasmid copies and then a 2-fold dilution
to 0.63 plasmid copies. The PyCytB standard curve was
derived from a serial 10-fold dilution ranging from 107 to 0.5
plasmid copies of CytB cDNA.
5. Primers and Probes
cDNA derived from P. yoelii 18S rRNA (Py18S) was
quantified by RT-PCR using a custom dual-labelled probe and
custom primers (Geneworks Pty. Ltd, SA). Both the probe and
the primer sequences have been previously published by us
( [11], Table 1), but the quencher used on the Py18S probe
was updated from TAMRA to BHQ-1. Amplification with these
primers generates a 98bp fragment (Figure 1C) that contains
69 mismatches (41.5% homology) with the homologous mouse
18S rRNA sequence (Rn18S; NCBI Gene ID: 19791; Figure 2).
P. yoelii cytochrome B mtDNA (PyCytB) specific primers and
probe were based on the previously published P. yoelii
(17XNL) CytB sequence (PY00774; NCBI Gene ID: 3792183)
and designed using the Primer3 software (http://simgene.com/
qRT-PCR for Plasmodium Liver-Stage Detection
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Primer3). Amplification with these primers generates a 207bp
fragment (Figure 1C) that contains 143 mismatches (41.6%
homology) with the homologous mouse cytochrome B mtDNA
sequence (Cyb561; Figure 2).
A commercially available qRT-PCR kit (TaqMan® Gene
Expression Assays from Applied Biosystems, Life
Technologies Australia Pty Ltd., Mulgrave, VIC) was used to
amplify mouse glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) as a housekeeping gene for the normalisation of
Py18S or PyCytB values.
6. qRT-PCR
Py18S and PyCytB qRT-PCR conditions were determined
empirically by testing a range of primer concentrations (range
0.2µM-1µM) and probe concentrations (range 0.1µM-0.5µM)
with different PCR reaction mixes in 15µl reactions with 2µl
cDNA. Specifically, we evaluated different DNA polymerases
(Platinum® Taq DNA Polymerase (Invitrogen, Life
Technologies Australia), AmpliTaq® Fast DNA Polymerase
(Applied Biosystems, Life Technologies Australia) and taq DNA
Polymerase (GE Healthcare Life Sciences)), different reverse
transcriptases (M-MLV Reverse Transcriptase (GE
Healthcare), SuperScript(R) III and SuperScript® Vilo reverse
transcriptase (Life Technologies Australia)) and different PCR
reaction mixes (Platinum® Taq PCR Mix (Invitrogen, Life
Technologies Australia), RT-PCR Master Mix (GE Healthcare
Life Sciences) and TaqMan(R) Fast Advanced Master Mix
(Applied Biosystems, Life Technologies Australia)). Optimal
amplification was achieved with primer concentrations at 1µM,
probe concentration at 250nM and Fast Advanced Master Mix
using a Rotorgene 3000A PCR machine (Corbett Research,
Mortlake, NSW) with the following conditions: 2 minutes at
50°C for calibration of fluorescence gain values, then
denaturing at for 2 minutes at 95°C, followed by 50 cycles of 5
seconds at 95°C and 30 seconds at 60°C (data not shown).
Non-template controls (H2O with 10µg/ml tRNA as carrier)
and liver samples of uninfected mice were included in each
run.
7. Analysis and Statistical Evaluation
All data was acquired on the Rotorgene 3000A and analysed
using Rotor-Gene software version 6.0 (both Corbett
Research). The cycle at which a defined threshold of
Table 1. Primer and probe sequences.
ID Sequence
Py18S rRNA probe* 5’ 6-FAM-CTGGCCCTTTGAGAGCCCACTGATT-BHQ-1 3’
Py685F* 5’ CTTGGCTCCGCCTCGATAT 3’
Py782R* 5’ TCAAAGTAACGAGAGCCCAATG 3’
PyCytB mRNA probe 5’ 6-FAM-TGCACGCTACTGGTGCATCA-BHQ-1 3’
PyCytB Fw 5’ GGAGTGGATGGTGTTTTAGA 3’
PyCytB Rv 5’ CACCCCAATAACTCATTTGT 3’
*. Sequences from [11]. The quencher on the Py18S rRNA probe dual labelling
was updated from TAMRA to BHQ-1.
doi: 10.1371/journal.pone.0077811.t001
fluorescence intensity is reached (quantification cycle, Cq) in
each sample is proportional to the amount of target sequence
in the extracted sample [18]. For our analysis, the threshold
was set at the point of inflexion of the PCR curve. The ‘plasmid
equivalents’ of target cDNA were calculated using a standard
curve derived from a dilution series of control plasmid. Data
generated in a qRT-PCR run was accepted only if non-
template controls and samples from uninfected control mice
were negative.
Since the starting amount of RNA used to generate cDNA
samples was constant between all samples, qRT-PCR directly
quantified the number of target molecules amplified from the
extracted sample. Reference genes were used to ensure
comparability between different samples, and control the
quality and yield of RNA extraction and the efficiency of cDNA
synthesis. The parasite liver burden in samples derived from P.
yoelii infected or uninfected mice was quantified by calculating
the ratio of ‘plasmid equivalents’ of Py18S rRNA or PyCytB
mtDNA to 106 units of GAPDH. The mean values and standard
deviation between technical replicates and the variance
between runs were calculated in Microsoft Office Excel 2007.
The limit of detection of P. yoelii parasites was defined as the
lowest number of ‘plasmid equivalents’ which could be
detected with 95% certainty for the target cDNA within liver
samples of sporozoite infected mice. High accuracy of
quantification of parasite cDNA in infected mouse liver samples
was defined below a cut-off value of 8x10-3 for the ratio
between standard deviation and mean of technical replicates.
Results
1. RNA integrity, cDNA synthesis
To determine the integrity of extracted RNA, we assessed
the ratio between the small (18S) and the large (28S) rRNA
subunit by gel electrophoresis; a 28S/18S ratio between 1 and
2 is indicative of an intact RNA sample [19]. Using our RNA
extraction method, there was no difference in the ratio of 28S
rRNA to 18S rRNA between freshly isolated RNA samples,
RNA samples frozen (-80°C) for one month and thawed
immediately prior to assay, or RNA extracted from frozen
(-80°C) and thawed liver homogenate (28S/18S= 1.3-1.6;
Figure 1A).
Next, we generated cDNA from a pooled liver RNA sample
using either SuperScript III reverse transcriptase or
SuperScript® VILOTM cDNA synthesis kit to optimise cDNA
synthesis. The SuperScript® Vilo cDNA synthesis kit has been
specifically designed to increase cDNA yields and improve the
dynamic range of qRT-PCR assays by promoting the cDNA
synthesis from rare RNA species in a complex sample. A 10-
fold dilution series of both cDNA samples was then analysed
by qRT-PCR for Py18S and PyCytB. cDNA synthesis
conducted with SuperScript® VILOTM cDNA synthesis kit
provided 10-fold higher sensitivity (data not shown) and was
thus chosen for all following cDNA synthesis reactions.
2. qRT-PCR optimisation
Py18S and PyCytB qRT-PCR conditions were determined
empirically by testing a range of primer and probe
qRT-PCR for Plasmodium Liver-Stage Detection
PLOS ONE | www.plosone.org 3 October 2013 | Volume 8 | Issue 10 | e77811
concentrations with different DNA polymerases and their
respective commercially available PCR reaction mixes (data
not shown), in 15µl reactions with 2µl cDNA. Optimal
amplification was achieved with primer concentrations at 1µM,
probe concentration at 250nM and Fast Advanced Master Mix
(data not shown) using a Rotorgene 3000 PCR machine
(Corbett Research, Mortlake, NSW).
3. Assay Validation
To validate the quantitative RT-PCR (qRT-PCR) assay, we
assessed the primer efficiency, dynamic range, and specificity
of the reaction using plasmid constructs containing Py18S or
PyCytB cDNA, or a pooled sample of cDNA derived from liver
homogenates of mice infected with varying amounts of
sporozoites. Sensitivity and accuracy was assessed from liver
RNA samples of mice infected with a titration of cryopreserved
sporozoites.
1. Efficiency of PCR amplification.  The efficiency of
amplification with Py18S or PyCytB primer sets under the
optimised qRT-PCR conditions was determined using a 2-fold
dilution series of a pool of cDNA samples derived from mouse
liver RNA extracts with varying parasite burden. Optimally, a
doubling in the amount of cDNA in each amplification cycle
results in exponential amplification to the base of 2. Thus, the
efficiency of the amplification can be calculated by determining
the slope of the curve described by the Cq values on the y-axis
and the log of the dilution factor on the x-axis and completing
following equation: amplification efficiency = 10^(-(1/slope))
[18]. Optimally, the value for efficiency is 2 (+/-10%). Values
between 1 and 2 indicate suboptimal amplification and values
higher than 2.2 are generally the result of primer dimers or non-
specific amplicons. The mean Cq values of two independent
PCR runs with two technical replicates and the resulting primer
efficiency for Py18S, PyCytB and GAPDH are presented in
Table 1. Both primer pairs showed optimal efficiency (Py18S:
2.04; PyCytB. 2.02) (Table 1). Furthermore, the difference in Cq
values between target genes and the reference gene (GAPDH)
is consistent across all sample dilutions, demonstrating the
suitability of normalisation of our target genes with GAPDH
(18S/GAPDH: 2.22±0.15; CytB/GAPDH: 2.29±0.17; 95%
confidence interval) (Table 1).
2. Dynamic Range.  The dynamic range and analytical
sensitivity of the qRT-PCR assay for Py18S was determined
using a dilution series of control plasmid encoding Py18S
covering seven log10 concentrations. The derived standard
curve for Py18S was linear (R2=0.998) over the range of 1.25
to 107 copies of template Py18S cDNA (Figure 1A). At 0.63
copies the qPCR was negative, indicating (analytical)
sensitivity down to 1.25 copies. The mean Cq value at the
lowest concentration was 39.03±0.23 (95% confidence interval)
and the variation at this concentration is within the range of
variation calculated for the whole linear interval (0.18-0.30,
95% confidence interval).
Similarly, the standard curve for our PyCytB qRT-PCR assay
derived from a serial dilution series of PyCytB control plasmid
over a range of 1 to 107 copies of template PyCytB cDNA was
linear (R2=0.9965) down to 1 copy (Figure 1B). The mean Cq
value at the limit of analytical sensitivity was 41.72±0.55 and
the variation across the whole linear interval ranged from 0.08
to 1.27 (95% confidence interval).
These Py18S and PyCytB standard curves were determined
using duplicate samples for each plasmid copy number and
repeated over three consecutive days to assess technical
variability of the qRT-PCR assay. The repeatability is
expressed as the standard deviation (s) between technical
replicates within one run, the mean standard deviation for all
three runs is displayed by the error bars in Figure 1. High
reproducibility was demonstrated by a low mean variance (s2)
between runs of the qRT-PCR assay for Py18S and for PyCytB
Figure 1.  Standard Curves.  qRT-PCR analysis of a dilution series ranging from 107 to 1 copies of Py18S (A) and PyCytB (B)
control plasmid. Data are presented as mean values for three independent runs with two technical replicates each. Error bars
represent mean standard deviation between technical replicates of each run.
doi: 10.1371/journal.pone.0077811.g001
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(Py18S: 0.07±0.02; PyCytB: 0.52±0.49; 95% confidence
interval).
3. Capacity to detect P. yoelii liver stage parasites.  The
capacity of the assay to quantitate a wide range of liver stage
parasite burdens was determined in BALB/c mice (3-7 per
group) injected with 50, 100, 500, 1000, 1500, 2000 and 5000
cryopreserved P. yoelii sporozoites. We previously established
that 50 cryopreserved sporozoites are sufficient to infect 100%
of BALB/c mice and that the pre-patent period in all mouse
cohorts was 6 days (data not shown). Standard curves for
Py18S and PyCytB covering plasmid copy numbers from 1 to
106 were used to determine the precise amount of parasite-
derived cDNA molecules in mouse liver samples by linear
regression analysis. In two independent runs Py18S qRT-PCR
detected parasite-derived cDNA in 95% of replicates from mice
infected with 50 sporozoites. The highest Cq value detectable
with at least 95% certainty was 38.5, corresponding to 1.5
Py18S molecules per reaction or 37.5 ‘plasmid equivalents’ per
2.5µg extracted RNA; thus these values represent the limit of
detection for our 18S qRT-PCR method (Figure 2). In all other
P. yoelii infected mice the detected parasite burdens were well
above the limit of detection. The amount of Py18S detected in
mice infected with 5000 cryopreserved sporozoites is
significantly different from mice infected with 2000
cryopreserved sporozoites (p=0.0286), and likewise for the
amount measured in mice injected with 1500 versus 1000
cryopreserved sporozoites (p=0.0159), 1000 versus 500
cryopreserved sporozoites (p=0.0079) and 100 versus 50
cryopreserved sporozoites (p=0.0357, Figure 2A). Linear
regression analysis shows that the number of injected
sporozoites is correlated to the number of detected parasite-
derived cDNA (R2=0.93; Figure 2A). Although the range of
Figure 2.  Limit of Detection after infection with different numbers of cryopreserved sporozoites.  Detection of (A) Py18S
rRNA or (B) PyCytB mRNA in liver RNA extracts of BALB/c mice 40h after infection with 50, 100, 500, 1000, 1500, 2000 or 5000
cryopreserved sporozoites. Data are represented as mean ‘plasmid equivalent’ for each group (n=3-7 mice/group). Two technical
replicates of each mouse sample were run twice in independent qRT-PCR experiments and the mean ‘plasmid equivalent’
measured for each mouse/group was calculated. The error bars represent the mean variation between mice receiving the same
sporozoite dose, calculated as the standard error for each group. A linear trendline was fitted to the data points to represent the
correlation of measured values to the number of injected sporozoites. The dotted line represents the limit of detection defined as the
mean value of target cDNA per 106 copies GAPDH within the group of samples for which a maximum of 5% of reactions failed.
Statistical significance between groups of mice receiving different sporozoite doses was evaluated using One-way ANOVA followed
by two-tailed Mann-Whitney test, * p<0.05, ** p<0.005.
doi: 10.1371/journal.pone.0077811.g002
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detected Py1S was larger in groups receiving low dose
sporozoite inocula (50-500 cryopreserved sporozoites), there
was no inverse correlation between infective dose and variation
between different mice of the same group. Thus, our Py18S
qRT-PCR assay can detect infection from as few as 50
cryopreserved sporozoites and reliably distinguish infected
from uninfected/protected animals after challenge with 100
cryopreserved sporozoites, as well as distinguish between
parasite burdens after low (50-500 sporozoite) or high
(1000-5000 sporozoites) dose infection.
PyCytB qRT-PCR could not detect parasite-derived cDNA in
liver samples of mice injected with 50 cryopreserved
sporozoites and also failed in 83% of replicates from mice
injected with 100 sporozoites, 40% of replicates from mice
injected with 500 sporozoites and 28.6% of replicates from
mice injected with 1000 replicates (Figure 2B). The highest Cq
value detectable with at least 95% certainty was 37.8,
corresponding to 10.3 molecules of PyCytB per reaction or
257.5 ‘plasmid equivalents’ per 2.5µg extracted RNA. Thus,
infection with 100 sporozoites is detectable, but infection with
at least 1500 sporozoites is necessary to reliably distinguish
infected from uninfected/protected mice using PyCytB as a
target gene in our qRT-PCR assay. The amount of PyCytB
detected in mice infected with 5000 cryopreserved sporozoites
is significantly different from mice infected with 2000
cryopreserved sporozoites (p=0.0195), as is the amount
measured after infection with 1500 versus 1000 cryopreserved
sporozoites (p=0.0061; Figure 2B). However, parasite burden
after infection with a range of low doses of less than 500
cryopreserved infectious sporozoites was not significantly
distinguishable. Although, linear regression analysis for PyCytB
qRT-PCR determines a strong correlation between the level of
sporozoite inoculum and detection of parasite-derived cDNA
(R2=0.93; Figure 2B), clinical sensitivity for PyCytB is
considerably lower than for Py18S (56.7% compared to 97%).
To confirm that all parasites detected by Py18S qRT-PCR
are derived from infectious sporozoites, which have invaded
and multiplied within hepatocytes, we injected mice with 2500
cryopreserved/live infectious or heat-inactivated sporozoites.
Figure 3.  Detection of infectious versus inactivated
sporozoites.  Viability of cryopreserved sporozoites (A) and
inactivation of heat-treated sporozoites (B) was confirmed by
fluorescence microscopy (DeltaVision Core Microscope
System with Coolsnap HQ camera and 100x/1.40 oil objective)
using Sytox Blue (0.1% in PBS).
doi: 10.1371/journal.pone.0077811.g003
Fluorescence microscopy confirmed that the majority of
sporozoites from the cryopreserved infectious inoculum were
live (by mobility and ability to exclude Sytox Blue) (Figure 3A),
and all sporozoites found in the heat-inactivated sample were
dead (by loss of mobility and Sytox Blue staining of DNA)
(Figure 3B). Parasite rRNA was below the limit of detection in
mice inoculated with heat-inactivated sporozoites, confirming
that only viable sporozoites which have invaded and multiplied
in the liver are detectable.
Notably, GAPDH qRT-PCR curves did not exhibit changes in
expression between samples from a wide range of
experimental conditions, indicating that amplification rates were
not influenced by the varying amount of parasite cDNA present
in different samples (Figure 3).
4. Specificity and Accuracy.  To confirm that only parasite
rRNA was amplified and to determine the effects of abundant
mouse rRNA on the qRT-PCR reaction, we spiked a cDNA
sample from a naïve BALB/c mouse with specific copy
numbers of Py18S control plasmid and measured the resulting
Cq values. The recovery rate was between 69-98%, with higher
accuracy in higher copy number ranges. Linear regression
analysis confirmed a robust linear correlation of measured to
known DNA amounts (R2=0.99) (Figure 4). Py18S was not
amplified from uninfected mouse samples, demonstrating
100% diagnostic specificity, thus indicating that the qRT-PCR
specifically amplifies 18S cDNA rather than non-specific
targets.
The accuracy of our qRT-PCR assay for both Py18S and
PyCytB target genes was determined by calculating the ratio of
standard deviation to mean copy number for four replicates
from two independent PCR runs and plotting it against the log10
of mean parasite-derived cDNA molecules as described in [20]
(Figure 5). Although low levels of parasite cDNA could be
detected in both assays, accuracy decreases with decreasing
parasite numbers as evidenced by the increase in standard
deviation between replicates. To ensure high accuracy of
parasite quantitation we suggest a cut-off at a standard
deviation/mean value of 8x10-3, resulting in a limit for high
accuracy at 1.6 molecules/reaction for our Py18S qRT-PCR
assay and at 66.5 molecules/reaction for our PyCytB qRT-PCR
assay.
Discussion
Rodent malaria parasites are widely used as model systems
for the study of the biology and pathology of Plasmodium spp.,
as well as for the evaluation of candidate vaccines or drugs. P.
yoelii is a robust model for pre-erythrocytic stage development
and ensuing protective immunity, and is often used in studies
evaluating vaccine or drug candidates [21,22].
Microscopic methods have been used to detect Plasmodium
spp. liver stages and describe the morphological development
of early and late hepatic stages [7], but are time-consuming,
insensitive, not accurately quantifiable, and not compatible with
high-throughput approaches. Recently, qRT-PCR and
bioluminescence or fluorescence measurements using
transgenic parasites have shown promising results in
evaluating liver stage parasite burden with high sensitivity
qRT-PCR for Plasmodium Liver-Stage Detection
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[1,3,10]. Fluorescent parasites have been generated and used
for the study of P. yoelii and P. berghei liver stages in different
mouse strains [8]. In one study, liver parasite burden after
infection with GFP transgene parasites was assessed by
fluorescence microscopy of perfused liver sections, revealing
that inoculation with 3x106 sporozoites resulted in 1000 liver
stage s/cm2. In other studies, GFP transgene parasites were
used to isolate infected hepatocytes by FACS sorting and to
detect parasite burden by intravital imaging through the
peritoneal cavity [8,23]. While these results demonstrate the
value of GFP transgenic parasites for cell culture and biological
characterisation of liver-stage parasites and infected
hepatocytes, issues with promoter choice and variance in GFP
expression [24] have limited the use of GFP parasites for the
evaluation of vaccine or drug induced reduction of parasite
burden in vivo. Luciferase expressing parasites on the other
hand have been used to evaluate the protective capacity of low
dose whole-parasite infection [25], the effect of blood-stage
infection on protective immunity against parasite liver-stages
[1] and the effect of various drugs [1] using in vivo imaging.
However, the luminescence signal associated with infection of
less than 1000 sporozoites was found to be indistinguishable
from background luminescence [1]. Moreover, the sensitivity of
bioluminescence imaging is limited by the low level expression
of luciferase in transgene parasites, so negative luminescence
signals cannot be definitively associated with low parasite
numbers in the liver or claims of sterile protection [25].
PCR-based methods have been described for the detection
and quantification of rodent Plasmodium spp. liver stages with
different RNA targets, including 28S rRNA and 18S rRNA
[10,11,13]. For example, one study in 1996 reported the
detection of liver-stage parasite burden after infection with only
200 sporozoites, but the results show that with these
inoculation numbers only 50% of infected mice were positive
for parasite rRNA in their qPCR assays, although all developed
blood-stage parasitaemia following challenge with 200
sporozoites [13]. In another study, parasite derived cDNA was
detected in mice infected with 25 freshly isolated sporozoites or
the bite of one infected mosquito [26].
Despite these technological developments, failure to reliably
detect low level liver-stage parasite infection directly impacts
on the standard infective dose used for challenge studies,
which can be well over 5,000 sporozoites [11]. The use of high
inoculums may overwhelm the host immune system resulting in
a failure to detect any partial protective effect at the liver stage
and thus provide incorrect and misleading results for partially
effective vaccines or drug candidates. Furthermore, mosquito
parasite loads can vary greatly [26] and neither infectivity nor
transmission of sporozoites through mosquito bites can be
quantified making the accurate assessment of the efficacy of
candidate drug or vaccines problematic. Improved techniques
for the production, dissection, purification and cryopreservation
of infectious Plasmodium spp. sporozoites from mosquito
salivary glands offer the possibility of highly accurate and
repeatable challenge studies [27]. Indeed, associated studies
have demonstrated that inoculation of sporozoites by mosquito
bite is much less efficient than inoculation by syringe [26] and
sporozoite infection via the intravenous route is generally found
to be the most successful means of achieving high hepatocyte
infection rates [27,28]. However, cryopreservation decreases
the infectivity of sporozoites and 7.5 times more cryopreserved
than fresh sporozoites are required to infect 50% of mice [29].
Using our qRT-PCR assay we were able to detect
sporozoites in 100% of mice infected with as few as 50
Figure 4.  Recovery rate.  A cDNA sample extracted from the liver of a naïve mouse was spiked with 7x105, 7x103 or 70 ‘plasmid
equivalents’ of Py18S control plasmid. Cq values of spiked samples were plotted on the y-axis against the given copy number of
plasmid. Linear regression analysis reveals a robust linear correlation of calculated to given copy numbers (R2=0.99). Data are
presented as mean values of three technical replicates; error bars represent the standard deviation.
doi: 10.1371/journal.pone.0077811.g004
qRT-PCR for Plasmodium Liver-Stage Detection
PLOS ONE | www.plosone.org 7 October 2013 | Volume 8 | Issue 10 | e77811
cryopreserved sporozoites (corresponding to approximately 7
freshly isolated sporozoites [29]) and reliably distinguish
infected from uninfected/protected mice after challenge with
100 cryopreserved sporozoites, as well as distinguish between
parasite loads derived from low or high dose inocula. This
assay therefore allows for a reduction of the standard infective
dose for challenge studies to 100 cryopreserved sporozoites or
10-15 freshly isolated sporozoites. Since mosquitoes are
thought to transmit around 100 infectious sporozoites per bite,
and challenge by intravenous injection of the bite of at least 2
and typically 5 mosquitoes is required for 100% infectivity, our
assay permits for the first time accurate quantitation of liver
stage parasites following low and biologically relevant parasite
challenge. We also achieved high accuracy for the quantitation
of very low amounts of parasite cDNA (1.6 copies of Py18S/
100ng extracted RNA) in liver samples of infected mice.
Previously qRT-PCR methods were not published with high
detail or consistency in terminology, making it difficult to
compare between the different methods [10,11,30,31]. The
MIQE guidelines were introduced in 2009 in order to target the
reliability of results to help ensure the integrity of the scientific
literature, promote consistency between laboratories, and
increase experimental transparency by describing the minimum
information necessary and provide authors, reviewers and
editors with these specifications [14,32]. In conformance with
these guidelines, we validated our optimised qRT-PCR assay
by determining the primer efficiency, dynamic range, specificity
and accuracy of parasite cDNA detection. We report a high
dynamic range (covering seven log10 concentrations) and high
recovery rates (69-98%) of parasite 18S rRNA within the
abundance of mouse RNA, by using SuperScript® Vilo for
cDNA synthesis and Fast Advanced Mix for qRT-PCR reaction.
The use of these improved conditions promotes detection of
Figure 5.  Accuracy of parasite cDNA detection.  The standard deviation for four replicates of one sample was divided by the
mean value for the target gene and plotted against the log of the mean parasite-derived cDNA copies/reaction. Each point
represents the mean of four replicates of one mouse liver cDNA sample. A cut-off value of 8x10-3 for the ratio between standard
deviation and mean is suggested for accurate quantitation. The dotted line marks the mean value between the highest amount of
parasite cDNA measured with a standard deviation/mean ratio below 8x10-3 and the highest amount of parasite cDNA measured
with a standard deviation/mean ratio above 8x10-3, for (A) Py18S qRT-PCR (1.6 copies/reaction) and for (B) PyCytB qRT-PCR (66.5
copies/reaction).
doi: 10.1371/journal.pone.0077811.g005
qRT-PCR for Plasmodium Liver-Stage Detection
PLOS ONE | www.plosone.org 8 October 2013 | Volume 8 | Issue 10 | e77811
rare RNA species and resulted in 10-fold increased sensitivity
and dynamic range of the qRT-PCR, in our hands.
Other gene targets have been suggested to confer higher
sensitivity due to higher abundance within the parasite genome
offering lower limits of detectable parasite numbers. With copy
numbers ranging from 30 to 100 per parasite in Plasmodium
spp., mtDNA was recently proposed as superior target to 18S
rRNA [17]. The cytochrome B (CytB) gene is one of the three
protein-encoding genes found in mtDNA, and has been widely
used to study phylogenetics and evolutionary relationships
among plasmodia [33]. For example, in one study, CytB qRT-
PCR was shown to be 16% more sensitive than 18S qRT-PCR
in human blood samples and could be used to detect and
distinguish various Plasmodium species in human saliva and
urine samples [17,34]. However, in our qRT-PCR assay,
detection of CytB in infected mouse liver samples was much
less sensitive than detection of Py18S rRNA with 15 times
higher sporozoite numbers being required to ensure reliable
distinction of infected and uninfected/protected individuals and
40 times higher numbers of parasite cDNA molecules required
for accurate quantitation.
In conclusion, we have established 18S rRNA as a reliable
target for a highly sensitive qRT-PCR assay which allows the
detection and accurate quantitation of P. yoelii liver stage
parasite burden after inoculation with as few as 50 sporozoites,
a much smaller dose than previously described and in the
same range as dose following natural challenge in the field
situation. This assay presents a valuable tool for the evaluation
of candidate drug and vaccines targeting pre-erythrocytic
parasite stages in the rodent model and allows the use of
parasite numbers close to those naturally occurring in field
challenge.
Supporting Information
Figure S1.  RNA integrity, target genes and amplicons. (A)
The integrity of RNA either, freshly extracted (lane 2), stored
for one month after extraction at -80°C (lane 3), or freshly
extracted from a liver homogenate stored at -80°C for one
month (lane 4) was assessed using gel electrophoresis on a
0.8% agarose gel. The densities of the large and small
subunits of rRNA were determined using Quantity One 1-D
analysis software (Bio-Rad Laboratories Pty. Ltd., NSW), and
the ratio was calculated. The 1kb DNA ladder from New
England Biolabs was used as a size reference marker (lanes 1
and 5). (B) Py18S rRNA (lane 2) and PyCytB mtDNA (lane 3)
were amplified from Plasmodium yoelii genomic DNA and
analysed by gel-electrophoresis on a 0.8% agarose gel. (C)
Py18S rRNA (lane 2) and CytB mtDNA (lane 3) amplicons after
50 cycles of qRT-PCR. The 1kb DNA ladder from New England
Biolabs is used as a size reference (lane 1).
(TIF)
Figure S2.  Primers and probe sequence alignment. (A)
Alignment of 18S primers (reverse primer: Py782R; forward
primer: Py685F) and probe with Py18S rRNA (Py18S) and
mouse 18S rRNA (Rn18S). (B) Alignment of CytB primers
(reverse primer: CytB Rv; forward primer: CytB Fw) and probe
with PyCytB (PY00774) and mouse Cytochrome B (Cyb561).
The analysis was performed using ClustalW2 (www.ebi.ac.uk).
(TIF)
Figure S3.  Reference genes.  The qRT-PCR curves of
mouse GAPDH across all evaluated mouse liver RNA samples
(N=62 data points) are presented together with the threshold
(defined at the point of inflexion of the PCR curves) at which Cq
values were determined.
(TIF)
Table S1.  Primer efficiency.  qRT-PCR was performed on a
2-fold dilution series of a pool (n=25) of mouse liver cDNA
samples infected with P. yoelii. *The slope of the curve
described by the Cq values on the y-axis and the log of the
dilution factor on the x-axis was determined using Microsoft
Office Excel 2007. Primer efficiency was calculated by
completing following equation: amplification efficiency= 10^ (-
(1/slope)). The ratio of Cq values for the target cDNA and
GAPDH was calculated for each dilution, in order to compare
efficiencies between target and reference genes.
(DOCX)
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